Cryoport, Inc. (NASDAQ:CYRX) Q3 2022 Results Conference Call November 3, 2022 5:00 PM ET
Company Participants
Todd Fromer - Managing Partner-KCSA
Jerrell Shelton - Chief Executive Officer
Robert Stefanovich - Chief Financial Officer
Dr. Mark Sawicki - Chief Scientific Officer
Thomas Heinzen - Vice President, Corporate Development and Investor Relations
Conference Call Participants
Puneet Souda - SVB Securities
John Sourbeer - UBS
Brandon Couillard - Jefferies
David Larsen - BTIG
David Saxon - Needham & Company
Yuan Zhi - B. Riley Securities
Jacob Johnson - Stephens
Operator
Good afternoon, and welcome to Cryoport's Third Quarter 2022 Earnings Conference Call. All participants will start in a listen-only mode. As a reminder, this call is being recorded.
I would now like to turn the call over to your host, Todd Fromer from KCSA Strategic Communications. Please go ahead.
Todd Fromer
Thank you, operator. Before we begin today, I would like to remind everyone that this conference call contains certain forward-looking statements. All statements that address our operating performance, events or developments that we expect or anticipate occurring in the future are forward-looking statements. These forward-looking statements are based on management's beliefs and assumptions and not on information currently available to our management team.
Our management team believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on any such forward-looking statements because such statements speak only as of the date we made. We do not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information or future events or otherwise, except as required by law.
In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results, events and developments to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in Item 1A, Risk Factors and elsewhere in our annual report on Form 10-K filed with the Securities and C Commission and those described from time to time in other reports which we file with the Securities and Exchange Commission.
It is my pleasure to turn the call over to Mr. Jerrell Shelton, Chief Executive Officer of Cryoport. Jerrell, the floor is yours.
Jerrell Shelton
Thank you, Todd. Good afternoon, ladies and gentlemen. We appreciate you joining our earnings call today. With us this afternoon is our Chief Financial Officer, Robert Stefanovich; our Chief Scientific Officer, Dr. Mark Sawicki; and our Vice President of Corporate Development and Investor Relations, Thomas Heinzen.